"What's In It for Me?" Taking PAT to the Executive Suite, Part 2

In this audio interview at his offices in Dublin, Paraic O'Toole, CEO of Automsoft, talks about the issues affecting PAT's future. Instead of thinking "technology," he says, corporate executives should view PAT as a tool to improve share prices and profitability. PhRMA could play a far more active role in educating the top brass, and FDA support, at the Commissioner level, would speed PAT's adoption.

By Agnes Shanley, Editor in Chief

Share Print Related RSS

Click the Download Now button below to hear Part 2 of this exclusive interview. To hear Part 1 of the interview, click here.

Share Print Reprints Permissions

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments